Correlation Between British Amer and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both British Amer and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining British Amer and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between British American Tobacco and Allovir, you can compare the effects of market volatilities on British Amer and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in British Amer with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of British Amer and Allovir.

Diversification Opportunities for British Amer and Allovir

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between British and Allovir is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding British American Tobacco and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and British Amer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on British American Tobacco are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of British Amer i.e., British Amer and Allovir go up and down completely randomly.

Pair Corralation between British Amer and Allovir

Considering the 90-day investment horizon British American Tobacco is expected to under-perform the Allovir. But the stock apears to be less risky and, when comparing its historical volatility, British American Tobacco is 2.71 times less risky than Allovir. The stock trades about -0.31 of its potential returns per unit of risk. The Allovir is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  726.00  in Allovir on July 5, 2022 and sell it today you would earn a total of  63.00  from holding Allovir or generate 8.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

British American Tobacco  vs.  Allovir

 Performance (%) 
       Timeline  
British American Tobacco 
British Performance
0 of 100
Over the last 90 days British American Tobacco has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in November 2022. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

British Price Channel

Allovir 
Allovir Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Allovir reported solid returns over the last few months and may actually be approaching a breakup point.

Allovir Price Channel

British Amer and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with British Amer and Allovir

The main advantage of trading using opposite British Amer and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if British Amer position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
British Amer vs. Amazon Inc
The idea behind British American Tobacco and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. BRP Inc
Allovir vs. Polaris Industries
Allovir vs. Arcimoto
Allovir vs. Harley-Davidson
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go